Innovation Sparks New Ideas at NORD’s Breakthrough Summit – Pediatric & Rare Liver Diseases News
Kristin Hatcher spent three days in Washington, D.C., at the NORD Breakthrough Summit to discuss equitable access to innovation.
Screening for MASLD is Cost-Effective for Patients – Fatty Liver Disease News
In this issue, we explore recent findings that highlight the need for dietary changes, including the link between ultra-processed foods and metabolic disorders in children with obesity, as well as the benefits of increasing plain water intake can reduce mortality risk.
Terri’s Story
When my doctor told me that I had fatty liver disease in 2015, the communication was that it was no big deal. In 2016, I was diagnosed with lupus then pancreatitis. Eventually, the pain, discomfort and fatigue from gallstones led me to an elective gallbladder surgery in 2017. During the surgery, my well-meaning surgeon found my liver to be nodular and decided to biopsy three separate spots while in the process of removing my gallbladder. What my surgeon did not know is how that biopsy would trigger a series of complications for my fragile liver.
Why Hepatitis C Treatment Matters: Improving Patient Outcomes Beyond Liver Health
Hepatitis C continues to be a significant public health concern with effects that reach beyond liver function. As a physician, you’re likely familiar with the chronic health challenges that accompany hepatitis C, especially in patients with multiple comorbidities.
Congress goes into recess in October while staff prepare for a potentially busy November lame-duck session – Liver Health Policy Update
Congress is in recess with Representatives and Senators back in districts and states connecting with their constituents prior to the elections. Their staff are working hard to prepare for what many hope to be a productive November legislative session where some legislative priorities may finally make it to final passage.